Results 161 to 170 of about 32,413 (228)

COVID-19 in children: Could pertussis vaccine play the protective role? [PDF]

Med Hypotheses, 2020
Ismail MB, Omari SA, Rafei R, Dabboussi F, Hamze M.   +4 more
europepmc   +1 more source

Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion Maternal Vaccine Coadministered With Diphtheria-Tetanus-Pertussis Vaccine: A Phase 2 Study. [PDF]

J Infect Dis
Hermida N, Ferguson M, Leroux-Roels I, Pagnussat S, Yaplee D, Hua N, van den Steen P, Anspach B, Dieussaert I, Kim JH.   +9 more
europepmc   +1 more source

A model based evaluation of the 1996-7 pertussis epidemic in the Netherlands

, 2001
van Boven, M., Melker, H.E., de, Boven, M., van, de Melker, H.E., Schellekens, J.F.P., Kretzschmar, M.   +5 more
core  

Repeated Bordetella pertussis Infections Are Required to Reprogram Acellular Pertussis Vaccine-Primed Host Responses in the Baboon Model. [PDF]

J Infect Dis
Kapil P, Wang Y, Zimmerman L, Gaykema M, Merkel TJ.   +4 more
europepmc   +1 more source

Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. [PDF]

PLoS Med
Pérez Chacón G, Estcourt MJ, Totterdell J, Marsh JA, Perrett KP, Campbell DE, Wood N, Gold M, Waddington CS, O' Sullivan M, McAlister S, Curtis N, Jones M, McIntyre PB, Holt PG, Richmond PC, Snelling T.   +16 more
europepmc   +1 more source

Correction: OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule. [PDF]

BMJ Open, 2022
europepmc   +1 more source

Acellular Pertussis Vaccines

New England Journal of Medicine, 1996
openaire   +3 more sources

Incidence of Myocarditis Associated with Diphtheria, Tetanus, and Pertussis Vaccine: A Rare Case Series. [PDF]

Int J Angiol
Iqbal M, Febrianora M, Putra ICS, Pramudyo M, Achmad C.   +4 more
europepmc   +1 more source

Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.

Lancet Glob Health
Nakabembe E, Greenland M, Amaral K, Abu-Raya B, Amone A, Andrews N, Cantrell L, Lesne E, Gorringe A, Halkerston R, Mcstraw N, Dixon L, Hunter OF, Heath PT, Imede E, Kyohere M, Musoke P, Nakimuli A, Sekikubo M, Taylor S, Tusubira V, Sadarangani M, Le Doare K.   +22 more
europepmc   +1 more source